Nuveen Asset Management, LLC Karuna Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $4.15 Million - $8.19 Million	-25,782 Reduced 16.06%	134,791 $42.7 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $1.69 Million - $2.24 Million	10,275 Added 6.84%	160,573 $27.2 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $541,478 - $737,715	3,071 Added 2.09%	150,298 $32.6 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $6.03 Million - $7.64 Million	37,370 Added 34.02%	147,227 $26.7 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $2.47 Million - $3.05 Million	12,871 Added 13.27%	109,857 $21.6 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $2.68 Million - $6.01 Million	21,681 Added 28.79%	96,986 $21.8 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $925,416 - $1.41 Million	9,848 Added 15.04%	75,305 $1.33 Million
Q1 2022 May 16, 2022	SELL	$98.9 - $132.37 $53,010 - $70,950	-536 Reduced 0.81%	65,457 $1.16 Million
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $667,159 - $961,182	-6,030 Reduced 8.37%	65,993 $1.17 Million
Q3 2021 Nov 12, 2021	SELL	$101.2 - $125.87 $1.33 Million - $1.66 Million	-13,155 Reduced 15.44%	72,023 $1.27 Million
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $1.81 Million - $2.29 Million	16,881 Added 24.72%	85,178 $1.51 Million
Q1 2021 May 17, 2021	SELL	$95.46 - $133.08 $44,770 - $62,414	-469 Reduced 0.68%	68,297 $1.21 Million
Q4 2020 Feb 16, 2021	SELL	$75.23 - $109.23 $133,458 - $193,774	-1,774 Reduced 2.51%	68,766 $1.22 Million
Q3 2020 Nov 16, 2020	SELL	$71.31 - $109.74 $134,276 - $206,640	-1,883 Reduced 2.6%	70,540 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $1.7 Million - $3.21 Million	27,392 Added 60.83%	72,423 $1.28 Million
Q1 2020 May 14, 2020	BUY	$60.41 - $115.92 $1.36 Million - $2.61 Million	22,538 Added 100.2%	45,031 $3.24 Million
Q4 2019 Feb 14, 2020	BUY	$11.44 - $123.99 $257,319 - $2.79 Million	22,493 New	22,493 $1.7 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account